JAGX Stock Analysis: Buy, Sell, or Hold?
JAGX - Jaguar Health, Inc.
$0.67
-0.02 (-2.39%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Get Alerted When JAGX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called JAGX this week
0% bullish • 2 bearish
0% bullish • 2 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: JAGX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: JAGX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: JAGX is currently trading at $0.67, which is considered oversold relative to its 30-day fair value range of $0.74 to $1.12.
Technical Outlook: Technically, JAGX is in a strong downtrend. The price is currently testing key support at $0.66. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: JAGX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $25.50 (+3589.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, JAGX is in a strong downtrend. The price is currently testing key support at $0.66. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: JAGX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $25.50 (+3589.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.74 -
$1.12
Company Quality Score
49/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
52.6%
Protect Your Profits
Holding JAGX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: Trading 3589.8% below Wall St target ($25.50)
- CAUTION: 5-day price weakness (-11.8%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$0.74 -
$1.12
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.66
Resistance Level
$1.87
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.12
Wall Street Target
$25.50
(+3589.8%)
Revenue Growth (YoY)
-0.8%
Last updated: January 30, 2026 5:43 PM ET
Data refreshes hourly during market hours. Next update: 6:43 PM
Data refreshes hourly during market hours. Next update: 6:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is JAGX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 59 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$141 | 59 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 56 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$42 | 64 BUY |
Advanced JAGX Option Strategies
Professional options setups generated by AI based on today's JAGX price and gamma walls.
